Search results
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Up 6.9% in April
ETF DAILY NEWS· 11 hours agoImmunoPrecise Antibodies Ltd. (NASDAQ:IPA – Get Free Report) was the target of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling ...
Chinese companies lead ADC pipeline
Pharmaceutical Technology via Yahoo Finance· 1 hour agoAntibody drug conjugates (ADCs) are a rapidly growing therapeutic class that leading data and analytics company GlobalData forecasts will generate more...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 20 minutes agoThe company also raised its sales outlook for the year. Meanwhile, Pfizer is tacking on new drug...
Transforming antibody therapy: Trellis Bioscience’s TRL1068 takes aim at antibiotic-resistant...
Digital Journal· 22 hours agoIn the fight against infectious diseases, such as Prosthetic Joint Infections (PJIs), finding truly...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
KLAS Las Vegas· 7 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced...
Patients with rheumatoid arthritis have unique and complex autoantibody patterns, study reveals
Medical Xpress· 14 hours agoRheumatoid arthritis is a chronic autoimmune disease that primarily affects the joints, causing...
Cancer Drugs: Strategies For Patenting Antibody-Drug Conjugate Inventions
The National Law Review· 2 days agoAntibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. Food...
Parkinson's: New treatment may help reduce motor symptoms
Medical News Today· 6 days agoPrasinezumab, a monoclonal antibody designed to target protein clumps in the brains of people with...
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of...
Digital Journal· 1 day agoProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative ...
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 6 hours agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70
